Table 5.
Critical patient-related adverse events | Transportsa (n) | Transports (%) |
---|---|---|
Total critical P-AEs | 146 | 33.1 |
Vital sign–related critical P-AEsb | 101 | 22.9 |
RR abnormality or more severe | 54 | 12.2 |
HR abnormality or more severe | 31 | 7.0 |
SBP abnormality or more severe | 21 | 4.7 |
SpO2 abnormality or more severe | 11 | 2.5 |
Arterial blood gas analysis–related critical P-AEsb | 66 | 15.0 |
pH abnormality or more severe | 2 | 0.5 |
PaO2 abnormality or more severe | 30 | 6.8 |
PaCO2 abnormality or more severe | 7 | 1.6 |
HCO3 − abnormality or more severe | 3 | 0.7 |
Lactate level abnormality or more severe | 28 | 6.4 |
Glucose level abnormality or more severe | 6 | 1.4 |
Accidental extubation | 1 | 0.2 |
Airway obstruction | 1 | 0.2 |
P-AE patient-related adverse events, RR respiratory rate, HR heart rate, SBP systolic blood pressure, SpO 2 pulse oximetry, PaO 2 partial pressure of oxygen in arterial blood, PaCO 2 partial pressure of carbon dioxide in arterial blood, HCO 3 − bicarbonate level
aNumber of transports with at least one AE
bDefined as a parameter with more severe abnormality detected (category 2 or worse in Fig. 2)